Predicting risk in type 1 diabetes

This update outlines the benefits and challenges of continuous glucose monitoring and time in range measurements in type 1 diabetes therapy

Need to know:

Effective management of blood glucose is crucial for individuals with type 1 diabetes (T1D) to minimise the risk of long-term risks and complications, including cardiovascular disease, neuropathy, nephropathy and retinopathy.

Traditionally, regular daily self-monitoring of capillary blood glucose and HbA1c have been used as primary markers for daily and longer-term glycaemic control, respectively.

However, with the development and more widespread use of continuous glucose monitoring (CGM), an additional approach, the time spent in target range, has emerged to support assessment of daily and long-term blood glucose management.1

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Content that breaches the privacy of other individuals
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .